A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes

NCT02069730 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

114

Enrollment

OTHER

Sponsor class

Conditions

Salivary Gland Cancer
Metastatic
Advanced
Recurrent

Interventions

DRUG: Selinexor
DRUG: EGFR or HER2 Inhibitor
DRUG: FGFR Inhibitor
DRUG: C-KIT Inhibitor
DRUG: Anti-androgen
DRUG: NOTCH Inhibitor
DRUG: MEK or PI3K Inhibitor

Sponsor

University Health Network, Toronto